It has been proposed that PD-1+CXCR6+ CD8+ T cells, which develop during the NASH stage, may promote HCC progression by killing hepatocytes in an auto-aggressive manner (93, 122). The gene discussed is CD8A; the disease is metabolic dysfunction-associated steatohepatitis.